Insider Cluster (2 insiders) ·Filed Mar 6, 2026

SUPN

SUPERNUS PHARMACEUTICALS, INC.
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago
Insider cluster: 4 insiders, $1.1M total
Actionable Insight • Neutral

The selling is routine in scale and not concentrated enough to signal distress; however, traders should monitor for additional selling in the next 30 days that could indicate broader concern.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
SUPN ▼ -16.91% at T+60d
NEUTRAL call ✗ call lost -16.91% · α vs SPY -29.69% · entry $53.87 → $44.76
Entry anchored
Mar 5, 03:59 PM ET
via exchange tick
T+1d
+0.56%
call +0.56% · α -0.29%
$54.17
settled 7mo ago
T+5d
-7.35%
call -7.35% · α -5.82%
$49.91
settled 7mo ago
T+20d
-6.18%
call -6.18% · α -4.14%
$50.54
settled 6mo ago
T+60d
-16.91%
call -16.91% · α -29.69%
$44.76
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two insiders at Supernus Pharmaceuticals sold shares in the past week, including a director and an SVP, with total open-market sales amounting to approximately $515,870. The transactions represent a modest level of insider selling, with both executives liquidating portions of their holdings at market prices.

Key Financial Metrics

Direction
selling
Total Value
$515.9K
Insiders
2

Key Facts

  • Director Hudson Frederick M. sold 5,369 shares on 2026-03-12 at $50.61, totaling $271,725.
  • SVP Commercial Operations Horich William Todd sold 4,439 shares on 2026-03-10 at $55, totaling $244,145.
  • Total open-market sales in the cluster: $515,870 across two insiders.
  • Sales represent approximately 0.018% of Supernus's $2.9B market cap — well below the 0.1% threshold for materiality.

Financial Impact

$515,870 in total open-market sales over 7 days

insider ownershipmarket sentiment

Risk Factors

  • Perception risk if additional insiders sell in coming weeks.
  • Commercial or pipeline developments could be misinterpreted as catalysts for the timing of these trades.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)cluster-SUPN-1773691685673
20 reports for SUPN
Performance horizon
75% Hit rate 6 of 8 directional calls best @ T+1▲ +8.46%Aug 3, 2026
Filters
Rows
Reports for SUPN — sortable, filterable
TypeNow
Sep 11, 2026
20d ago
DEFM14A
MIXED ★ 7/10
$41.49 $42.78▲ +3.11%▲ +3.00%$42.38 (+2.15%)
Aug 3, 2026
8w ago
DEFA14A / 425
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$42.38 (−2.01%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$42.38 (−2.01%)
Aug 3, 2026
8w ago
DEFA14A / 425
BULLISH ★ 8/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.38 (−7.87%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 7/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.38 (−7.87%)
Aug 3, 2026
8w ago
8-K
MIXED ★ 7/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.38 (−7.87%)
Aug 3, 2026
8w ago
DEFA14A / 425 / 8-K
BULLISH ★ 8/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.38 (−7.87%)
Jul 22, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$47.19 $45.61▼ −3.35%▼ −3.82%$42.38 (−10.19%)
Jul 22, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$47.19 $45.61▼ −3.35%▼ −3.82%$42.38 (−10.19%)
Jul 20, 2026
10w ago
Court Ruling
NEUTRAL ★ 3/10
$47.42 $46.20▼ −2.57%▼ −2.15%$42.38 (−10.63%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (65h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 16, 2026